A Natural History Study of Patients with Osteogenesis Imperfecta in Italy - Studio di storia naturale in pazienti con osteogenesi imperfetta in Italia

Title

Code

Saturn

Type

Osservazionale

Start Year

2023

Status

In Corso

Principal Investigator

051-6366062

marina.mordenti@ior.it

Mordenti Marina, MSc, PhD

Researcher

Rare skeletal disorders

Operational unit that carry out the study

complex unit

Malattie rare scheletriche

Director

Sangiorgi Luca, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Saturn

Tuesday 5 September 2023, 11:48

PG0012745_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

A Natural History Study of Patients with Osteogenesis Imperfecta in Italy - Studio di storia naturale in pazienti con osteogenesi imperfetta in Italia

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in